|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/24 | |
| C12N 15/13 | |||
| A61P 35/00 | |||
| A61K 39/395 | |||
| A61P 37/02 |
| (11) | Patento numeris | 2087005 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07824720.2 |
| Europos patento paraiškos padavimo data | 2007-11-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-08-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-02-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2007/004527 |
| Data | 2007-11-28 |
| (87) | Numeris | WO 2008/065378 |
| Data | 2008-06-05 |
| (30) | Numeris | Data | Šalis |
| 861704 P | 2006-11-30 | US |
| (72) |
MALLINDER, Philip, GB
LANE, Steven Godfrey, GB
CRUWYS, Simon Charles, GB
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
MEDIMMUNE LIMITED, Milstein Building Granta Park, Cambridge Cambridgeshire CB21 6GH, GB |
| (54) | ANTI-HUMAN IL-6 ANTIBODIES |
| ANTI-HUMAN IL-6 ANTIBODIES |